Literature DB >> 6292106

Antibody-dependent cell-mediated cytotoxicity against varicella-zoster virus-infected targets.

H Kamiya, S E Starr, A M Arbeter, S A Plotkin.   

Abstract

Antibody-dependent cell-mediated cytotoxicity (ADCC) against cryopreserved varicella-zoster virus-infected human foreskin fibroblasts was detected in a 51Cr release assay. Target cells, samples of seropositive or seronegative sera, and mononuclear cells obtained by Ficoll-Hypaque centrifugation of human peripheral blood were added to microtiter plate wells and allowed to incubate at 37 degrees C for 4 h. Fibroblasts infected for 48 to 96 h were susceptible to ADCC. Effector cells from seropositive and seronegative normal children were equally active in the assay. Antibody titers were determined by testing serial dilutions of sera in the ADCC assay. Zoster immune globulin had a titer of 204,800. Sera from 40 naturally seropositive individuals were compared by assays for ADCC and fluorescent antibody to membrane antigen. All sera that were negative by fluorescent antibody to membrane antigen (less than 2) were also negative by ADCC (less than 20). All sera that were positive by fluorescent antibody to membrane antigen were also positive by ADCC, but titers of individual sera were frequently 5 to 20 times higher in the ADCC assay.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6292106      PMCID: PMC347774          DOI: 10.1128/iai.38.2.554-557.1982

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  10 in total

1.  The influence of certain salts, amino acids, sugars, and proteins on the stability of rickettsiae.

Authors:  M R BOVARNICK; J C MILLER; J C SNYDER
Journal:  J Bacteriol       Date:  1950-04       Impact factor: 3.490

Review 2.  Passive immunization against varicella-zoster infections and other modes of therapy.

Authors:  P A Brunell; A A Gershon
Journal:  J Infect Dis       Date:  1973-04       Impact factor: 5.226

3.  Serologic response to varicella-zoster membrane antigens measured by direct immunofluorescence.

Authors:  V Williams; A Gershon; P A Brunell
Journal:  J Infect Dis       Date:  1974-12       Impact factor: 5.226

4.  A rapid radioimmunoassay using 125I-labeled staphylococcal protein A for antibody to varicella-zoster virus.

Authors:  D D Richman; P H Cleveland; M N Oxman; J A Zaia
Journal:  J Infect Dis       Date:  1981-05       Impact factor: 5.226

5.  Transfer factor and cellular reactivity to varicella-zoster antigen in childhood leukemia.

Authors:  R W Steele
Journal:  Cell Immunol       Date:  1980-03-15       Impact factor: 4.868

6.  Human monocyte-macrophage-mediated antibody-dependent cytotoxicity to herpes simplex virus-infected cells.

Authors:  S Kohl; S E Starr; J M oleske; S L Shore; R B Ashman; A J Nahmias
Journal:  J Immunol       Date:  1977-03       Impact factor: 5.422

7.  Human polymorphonuclear leucocytes as mediators of antibody-dependent cellular cytotoxicity to herpes simplex virus-infected cells.

Authors:  J M Oleske; R B Ashman; S Kohl; S L Shore; S E Starr; P Wood; A J Nahmias
Journal:  Clin Exp Immunol       Date:  1977-03       Impact factor: 4.330

8.  The mononuclear cell in human blood which mediates antibody-dependent cellular cytotoxicity to virus-infected target cells. I. Identification of the population of effector cells.

Authors:  S L Shore; F M Melewicz; D S Gordon
Journal:  J Immunol       Date:  1977-02       Impact factor: 5.422

9.  Cell-mediated immunity to varicella-zoster virus demonstrated by viral inactivation with human leukocytes.

Authors:  A A Gershon; S Steinberg; M Smith
Journal:  Infect Immun       Date:  1976-06       Impact factor: 3.441

10.  Inactivation of varicella zoster virus in vitro: effect of leukocytes and specific antibody.

Authors:  A A Gershon; S P Steinberg
Journal:  Infect Immun       Date:  1981-08       Impact factor: 3.441

  10 in total
  8 in total

1.  Interleukin 2 enhances natural killing of varicella-zoster virus-infected targets.

Authors:  M Ito; S Bandyopadhyay; M Matsumoto-Kobayashi; S C Clark; D Miller; S E Starr
Journal:  Clin Exp Immunol       Date:  1986-07       Impact factor: 4.330

2.  Human leukocytes kill varicella-zoster virus-infected fibroblasts in the presence of murine monoclonal antibodies to virus-specific glycoproteins.

Authors:  M Ito; T Ihara; C Grose; S Starr
Journal:  J Virol       Date:  1985-04       Impact factor: 5.103

3.  Inhibition of varicella-zoster virus in vitro by human peripheral blood mononuclear cells.

Authors:  G P Rabalais; F E Berkowitz; A R Hayward; M J Levin
Journal:  Clin Exp Immunol       Date:  1989-03       Impact factor: 4.330

4.  Human polymorphonuclear leukocyte-mediated cytotoxicity against varicella-zoster virus-infected fibroblasts.

Authors:  T Ihara; S E Starr; M Ito; S D Douglas; A M Arbeter
Journal:  J Virol       Date:  1984-07       Impact factor: 5.103

5.  Antibody-dependent cell-mediated cytotoxicity against IBR-infected bovine kidney cells by ruminant neutrophils: the role of lysosomal cationic protein.

Authors:  K J Thorne; J M Norman; S F Haydock; D A Lammas; P H Duffus
Journal:  Immunology       Date:  1984-10       Impact factor: 7.397

6.  Human lymphocyte, monocyte and polymorphonuclear leucocyte mediated antibody-dependent cellular cytotoxicity against varicella-zoster virus-infected targets.

Authors:  T Ihara; M Ito; S E Starr
Journal:  Clin Exp Immunol       Date:  1986-01       Impact factor: 4.330

7.  Safety and Varicella Outcomes in In Utero-Exposed Newborns and Preterm Infants Treated With Varicella Zoster Immune Globulin (VARIZIG): A Subgroup Analysis of an Expanded-Access Program.

Authors:  Jennifer M Duchon; Myron J Levin; Anne A Gershon
Journal:  J Pediatric Infect Dis Soc       Date:  2020-09-17       Impact factor: 3.164

Review 8.  Alphaherpesvirus Vaccines.

Authors:  Clare Burn Aschner; Betsy C Herold
Journal:  Curr Issues Mol Biol       Date:  2020-09-23       Impact factor: 2.081

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.